logo-loader

Acorda Therapeutics Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$87.9 m
Price
1.83 USD
Change
-5.18%
52 weeks high
21.08
52 weeks low
1.58

In brief

Acorda Therapeutics is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system.